• Blog
  • Transcatheter Mitral Valve Replacement (TMVR) Market Report

    Transcatheter Mitral Valve Replacement (TMVR) Market Report

    Transcatheter Mitral Valve Replacement (TMVR) Market Report
    Report code - SRHL237 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Transcatheter Mitral Valve Replacement (TMVR) Market, Dynamics, and Market Analysis See more...

    Market Insights

    The Global Transcatheter Mitral Valve Replacement (TMVR) Market is expected to grow from USD 887.3 million in 2020 to USD 3,437.5 million by 2026 at a CAGR of over 26.0% during the forecast period.

    Figure: Global Transcatheter Mitral Valve Replacement (TMVR) Market Size, 2020-2026 (USD Million)

    Transcatheter-Mitral-Valve-Replacement-(TMVR)-Market-Forecast

    Wish to get a sample report? Click here.

    What is a Transcatheter mitral valve replacement?

    A transcatheter mitral valve replacement is defined as a non-surgical, minimally invasive procedure used to replace a dysfunctional mitral valve. The Mitral valve is a valve with two flaps in the heart and it lies between the left ventricle and atrium. MitraClip, Edwards PASCAL, and Edwards SAPIEN 3 are commonly used to treat mitral regurgitation diseases.

    Key Players

    Key players operating in the global Transcatheter Mitral Valve Replacement (TMVR) Market are-

    • Abbott Laboratories (The U.S),
    • Micro Interventional Devices, Inc. (The U.S),
    • Edward Lifecsiences Incorporation (The U.S),
    • Neovasc Inc. (Canada), Medtronic plc (The U.S),
    • Biotronik (Germany), Colibri Heart Valve LLC (The U.S),
    • LivaNova, PLC (UK),
    • NeoChord, Inc. (The U.S), and
    • Coramaze technologies GmbH (Germany).

    Market Dynamics

    The growth of the global transcatheter mitral valve replacement (TMVR) market is primarily driven by an increasing number of people particularly the geriatric population suffering from cardiovascular diseases.

    • Growing emphasis on developing technologically advanced solutions in surgical procedures is projected to propel the market growth at a significant rate during the review period.
    • Additionally, increasing demand for minimally invasive procedures over open-heart surgeries is also propelling the market growth substantially.
    • Furthermore, increasing prevalence of valvular diseases in the developing countries owing to changing lifestyle is likely to create lucrative growth opportunities for the player operating in the global TMVR market in the coming years.

    Segment Analysis

    Application Trends

    Based on application, the market has been segmented into functional mitral regurgitation (FMR) and degenerative mitral regurgitation (DMR).

    • The functional mitral regurgitation segment accounted for the largest market share in 2020.
    • This market growth can be attributed to increasing number of people suffering from mitral regurgitation (MR).
    • Functional mitral valve regurgitation occurs when the left atrium or left ventricle dilates due to which the mitral valve annulus also dilates and prevent the mitral valve leaflets from properly coapting.

    Regional Trends

    Geographically, the market in North America accounted for the largest market share of more than 30% in 2020.

    • The market growth can be attributed to presence of a large number of people suffering from cardiac diseases.
    • More than 2.5% of the U.S. population has valvular heart disease, most commonly among adults.
    • The market in Asia-Pacific is expected to increase at a healthy CAGR during the review period on account of increasing demand for advanced surgical procedures to treat heart diseases.

    COVID-19 Impact on Global Transcatheter Mitral Valve Replacement (TMVR) Market

    The covid-19 outbreak did not affect the growth of the Transcatheter mitral valve replacement (TMVR) market as unlike other medical problems treating heart-related problems cannot be postponed. MR is a life-threatening disease and thus, must be treated as and when required.  The American College of Cardiology (ACC) and Society of Cardiac Angiography and Interventions (SCAI) also established guidelines regarding considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic.

    Critical Questions Answered in the Report

    • What are the key trends in the global transcatheter mitral valve replacement (TMVR) market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global transcatheter mitral valve replacement (TMVR) market?
    • What are the key strategies adopted by the major vendors to lead in the global transcatheter mitral valve replacement (TMVR) market?
    • What is the market share of the top vendors?

    Want to know the full scope of the report? Register Here

    Target Audience

    Here is the list of the group of customers that the Global Transcatheter Mitral Valve Replacement market hopes to have the greatest opportunity to convert-

    • Transcatheter mitral valve replacement (TMVR) manufacturers
    • Transcatheter mitral valve replacement (TMVR) suppliers
    • Transcatheter mitral valve replacement (TMVR) distributors
    • Organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The transcatheter mitral valve replacement market is expected to witness an impressive growth of 26.0% CAGR in the foreseeable future.

    Abbott Laboratories (The U.S), Micro Interventional Devices, Inc. (The U.S), Edward Lifecsiences Incorporation (The U.S), Neovasc Inc. (Canada), Medtronic plc (The U.S), Biotronik (Germany), Colibri Heart Valve LLC (The U.S), LivaNova, PLC (UK), NeoChord, Inc. (The U.S) and Coramaze technologies GmbH (Germany) are among the key players in the transcatheter mitral valve replacement market.

    The transcatheter mitral valve replacement market size is expected to reach USD 3,437.5 million in the coming years.

    North America accounted for the largest share of transcatheter mitral valve replacement market in 2020.

    The functional mitral regurgitation segment accounted for the largest share of the transcatheter mitral valve replacement market in 2020.

    Increasing number of people particularly the geriatric population suffering from cardiovascular diseases, growing emphasis on developing technologically advanced solutions in surgical procedures, increasing demand for minimally invasive procedures over open-heart surgeries are the factors driving the growth of transcatheter mitral valve replacement market.

    Transcatheter mitral valve replacement (TMVR) manufacturers, Transcatheter mitral valve replacement (TMVR) suppliers, Transcatheter mitral valve replacement (TMVR) distributors, Organizations, Government bodies are the target audience in the transcatheter mitral valve replacement market.

    •